Gemmer Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $277K | Sell |
|
|||||
|
2023
Q4 | $430K | Hold |
|
|||||
|
2023
Q3 | $313K | Hold |
|
|||||
|
2023
Q2 | $380K | Sell |
|
|||||
|
2023
Q1 | $433K | Sell |
|
|||||
|
2022
Q4 | $556K | Hold |
|
|||||
|
2022
Q3 | $489K | Hold |
|
|||||
|
2022
Q2 | $599K | Hold |
|
|||||
|
2022
Q1 | $642K | Sell |
|
|||||
|
2021
Q4 | $654K | Hold |
|
|||||
|
2021
Q3 | $466K | Hold |
|
|||||
|
2021
Q2 | $510K | Hold |
|
|||||
|
2021
Q1 | $424K | Hold |
|
|||||
|
2020
Q4 | $398K | Hold |
|
|||||
|
2020
Q3 | $321K | Sell |
|
|||||
|
2020
Q2 | $347K | Buy |
|
|||||
|
2020
Q1 | $169K | Hold |
|
|||||
|
2019
Q4 | $377K | Hold |
|
|||||
|
2019
Q3 | $82K | Buy |
|
|||||
|
2019
Q2 | $130K | Hold |
|
|||||
|
2019
Q1 | $122K | Hold |
|
|||||
|
2018
Q4 | $114K | Hold |
|
|||||
|
2018
Q3 | $217K | Hold |
|
|||||
|
2018
Q2 | $177K | Hold |
|
|||||
|
2018
Q1 | $211K | Hold |
|
|||||
|
2017
Q4 | $145K | Hold |
|
|||||
|
2017
Q3 | $158K | Buy |
|
|||||
|
2017
Q2 | $62K | Hold |
|
|||||
|
2017
Q1 | $81K | Hold |
|
|||||
|
2016
Q4 | $75K | Hold |
|
|||||
|
2016
Q3 | $76K | Hold |
|
|||||
|
2016
Q2 | $194K | Hold |
|
|||||
|
2016
Q1 | $139K | Buy |
|
|||||
|
2015
Q4 | $161K | Hold |
|
|||||
|
2015
Q3 | $120K | Buy |
|
|||||
|
2015
Q2 | $32K | Hold |
|
|||||
|
2015
Q1 | $24K | Buy |
|